Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-52.89	47.21	100.21
Graham Fair Price	-19.21	25.34	31.37
PEG	-83.69	-0.19	1.16
Price/Book	16.02	2.26	1.94
Price/Cash Flow	-184.13	-599.63	-211.04
Prices/Earnings	84.69	31.19	-16.89
Price/Sales	-3.69	16.99	17.64
Price/FCF	-184.13	-599.63	-211.04
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	2401.65	0.19	< 0.005
Operating Margin	-86.26	0.03	-0.24
ROA	-37.64	0.01	-0.02
ROE	-0.03	0.02	-37.18
ROIC	-0.02	0.02	-27.33
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.01	0.01	19.33
Dividends QOQ	0.01	-0.02	27.16
EBIT QOQ	0.23	1.17	400.36
EPS QOQ	0.15	1.64	1032.71
FCF QOQ	0.67	0.58	-13.62
Revenue QOQ	0.18	0.23	30.12
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	156.45	160.14	2.36
Days Sales Outstanding (DSO)	56.05	66.39	18.45
Inventory Turnover	0.58	0.56	-2.31
Debt/Capitalization	0.25	0.25	-0.60
Quick Ratio	2.01	2.13	5.67
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	38.99	39.74	1.93
Cash	8.23	8.16	-0.82
Capex	-1.63	-1.25	23.22
Free Cash Flow	-0.36	-0.15	58.38
Revenue	4.30	5.28	22.79
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	3.53	3.74	6.01
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.76	2.83	-58.20
Naive Interpretation	Member

06 - Financial Health · Bad

Rating